NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) is an Australian drug development company developing novel peptide-based pharmaceutical products that target a number of neurodegenerative conditions with high unmet medical need. 

Therapeutic indications include Alzheimer’s Disease, Multiple Sclerosis, Glaucoma and Post-Covid Lung Fibrosis. 

The companies lead compound, EmtinB works by effectively slowing down the death of dying cells and regenerating damaged nerves and tissue fibres.

NeuroScientific Biopharmaceuticals is committed to a research and development program that is methodically planned, efficiently executed and risk aware.

www.neuroscientific.com


Biotechnology

Health Care

Health Diagnostics

Therapeutics

NeuroScientific Biopharmaceuticals Ltd

NeuroScientific Biopharmaceuticals Ltd's headquarters in Cottesloe, Australia

Description

People (1)

Anton Uvarov Mba

Jobs